IN VITRO DIAGNOSTICS (IVD) KITS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-09-13 | Pages: 200+ | Report ID: WR-2024-09-13-192490 | Technology
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
In Vitro Diagnostics (IVD) Kits Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET
7.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA IN VITRO DIAGNOSTICS (IVD) KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Siemens Healthcare
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Johnson and Johnson
16.3 Becton Dickinson
16.4 Abbott Laboratories
16.5 Roche Diagnostics
16.6 Beckman Coulter Inc
16.7 Thermo Scientific
16.8 Cobas
16.9 Caprion
16.10 Merck Millipore
16.11 Aptiv Solution
16.12 Danaher Corporation
16.13 Biomerieux
16.14 Bio-Rad Laboratories
16.15 Ortho Clinical Diagnostics
16.16 Sysmex Corporation
16.17 Mindray
16.18 Shanghai Kehua Bio-engineering
16.19 BioSino Bio-technology
16.20 Beijing Leadman Biochemistry
16.21 DAAN Gene
16.22 Creative Diagnostics
16.23 Illumina
16.24 Luminex Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Segment by TypeBlood
Urine
Stool
Tissue Cells
Segment by Application
Physical Examination
Chronic Disease Management
Heavy Disease Surveillance
Other
Companies
Siemens Healthcare
Johnson and Johnson
Becton Dickinson
Abbott Laboratories
Roche Diagnostics
Beckman Coulter Inc
Thermo Scientific
Cobas
Caprion
Merck Millipore
Aptiv Solution
Danaher Corporation
Biomerieux
Bio-Rad Laboratories
Ortho Clinical Diagnostics
Sysmex Corporation
Mindray
Shanghai Kehua Bio-engineering
BioSino Bio-technology
Beijing Leadman Biochemistry
DAAN Gene
Creative Diagnostics
Illumina
Luminex Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.